News Related to Ichthyosis Vulgaris

Related coverage linked through entity extraction aliases.

Zydus Lifesciences Secures FDA Approvals for Pediatric PAH Drug and Ammonium Lactate Cream

Feb 27, 2026

Zydus Lifesciences received USFDA final approval for 32 mg bosentan tablets for pediatric PAH and Ammonium Lactate Cream, 12%, while launching an affordable respiratory device in India.

Zydus Receives FDA Final Approval for Ammonium Lactate Cream, 12%

Feb 15, 2026

Zydus Lifesciences Limited received final FDA approval for Ammonium Lactate Cream, 12%, a generic of Lac-Hydrin Cream. The topical prescription medication treats xerosis and ichthyosis vulgaris, with annual U.S. sales of $15 million.